Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.05    -0.80 (-1.74%)
Bid:
45.00
Ask:
45.15
Spread: 0.15 (0.333%)
Market Cap: £285.10m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Statement regarding press speculation

29 Jan 2021 11:24

RNS Number : 3843N
Marston's PLC
29 January 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

Friday 29th January, 2021Marston's PLC

Statement regarding press speculation

The Board of Marston's PLC ("Marston's" or the "Company") notes the press speculation and confirms that it has today received an unsolicited non-binding proposal from Platinum Equity Advisors, LLC ("Platinum") regarding a possible cash offer for the entire issued, and to be issued, share capital of Marston's (the "Proposal").

The Board will evaluate the Proposal with its advisers and a further announcement will be made in due course. There can be no certainty that any firm offer will be made for the Company, nor as to the terms on which any firm offer might be made.

In accordance with Rule 2.6(a) of the Code, Platinum, is required, by no later than 5.00 p.m. (London time) on Friday 26th February 2021, being 28 days after today's date, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel (the "Panel") in accordance with Rule 2.6(c) of the Code.

Enquiries:

 

Marston's PLC

Tel: 01902 329516

Ralph Findlay, CEO

Andrew Andrea, CFO

J.P. Morgan Cazenove

Tel: 020 7742 4000

James Mitford / Anastasia Volnova

Dwayne Lysaght / Jonty Edwards

Instinctif Partners

Tel: 020 7457 2010/2005

Justine Warren

Matthew Smallwood

 

 

Disclaimer

J.P. Morgan Securities PLC, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Marston's and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Marston's for providing the protections afforded to clients of J.P. Morgan Cazenove, or for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.marstons.co.uk, by no later than 12 noon (London time) on 1st February 2021. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) of the Code applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8 of the Code. A Dealing Disclosure by a person to whom Rule 8.3(b) of the Code applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCUKUARAUUAUAR
Date   Source Headline
1st Oct 20183:21 pmRNSTotal Voting Rights
21st Sep 20183:04 pmRNSHolding(s) in Company
20th Sep 201810:21 amRNSHolding(s) in Company
19th Sep 20188:12 amRNSDirector Declaration
17th Sep 20189:57 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSAppointment of Chairman
5th Sep 20182:00 pmRNSHolding(s) in Company
21st Aug 20189:07 amRNSHolding(s) in Company
14th Aug 20189:29 amRNSHolding(s) in Company
7th Aug 201812:23 pmRNSDirector/PDMR Shareholding
2nd Aug 20188:46 amRNSDirector Declaration
31st Jul 20187:30 amRNSDirector Declaration
25th Jul 20182:15 pmRNSDirector Declaration
25th Jul 20187:00 amRNSTrading Update
19th Jul 20188:47 amRNSDirector Declaration
10th Jul 20181:38 pmRNSBlock listing Interim Review
3rd Jul 20182:19 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.